Livingstone, E., Gogas, H. J., Kandolf, L., Meier, F., Eigentler, T. K., Ziemer, M., . . . Schadendorf, D. (2025). Early switch from run-in with targeted to immunotherapy in advanced BRAFV600-positive melanoma: Final results of the randomised phase II ImmunoCobiVem trial. ESMO open, 10(5), . https://doi.org/10.1016/j.esmoop.2025.105053
Chicago-Zitierstil (17. Ausg.)Livingstone, Elisabeth, et al. "Early Switch from Run-in with Targeted to Immunotherapy in Advanced BRAFV600-positive Melanoma: Final Results of the Randomised Phase II ImmunoCobiVem Trial." ESMO Open 10, no. 5 (2025). https://doi.org/10.1016/j.esmoop.2025.105053.
MLA-Zitierstil (9. Ausg.)Livingstone, Elisabeth, et al. "Early Switch from Run-in with Targeted to Immunotherapy in Advanced BRAFV600-positive Melanoma: Final Results of the Randomised Phase II ImmunoCobiVem Trial." ESMO Open, vol. 10, no. 5, 2025, https://doi.org/10.1016/j.esmoop.2025.105053.